纳米粒子在癌症治疗中:化疗增强和ROS生成
Emmanuel Faderin1, Terungwa H Iorkula2, Omowunmi Rebecca Aworinde3
1Department of Pharmaceutical Sciences, Southern Illinois University, Edwardsville, 1 Hairpin Drive, Edwardsville, IL, 62026-001, USA.
Medical oncology (Northwood, London, England)
|January 9, 2025
概括
纳米粒子 (PtNPs) 通过向瘤并通过活性氧物种 (ROS) 诱导癌细胞死亡来增强化疗. 纳米技术的进步提高了PtNP的输送和疗效,在癌症治疗的临床试验中显示出有前途.
科学领域:
- 纳米医学是一种纳米医学.
- 生物技术是生物技术.
- 癌症治疗方法 癌症治疗方法
背景情况:
- 纳米颗粒 (PtNPs) 正成为增强基化疗的有希望的策略.
- PtNP提供了改进的瘤向,减少了全身毒性,以及克服药物耐药性的机制.
- 目前的研究重点是优化PtNP特征以提高治疗结果.
研究的目的:
- 审查纳米颗粒在癌症治疗中的作用机制.
- 探索PtNP纳米技术的进步,以改善药物输送和生物相容性.
- 讨论PtNP在临床癌症治疗方案中的潜在整合.
主要方法:
- 关于PtNP在癌症治疗中的现有文献的综述.
- 对PtNP合成,功能化和药物输送系统的分析.
- 检查PtNP功效和生物相容性的体外和体内研究.
主要成果:
- PtNP主要通过产生活性氧物种 (ROS) 诱导抗癌作用,从而导致氧化应激和亡.
- PtNP调节关键的细胞信号通路 (例如PI3K/AKT,MAPK),增强癌细胞的化学敏感性.
- 在体内研究表明,PtNPs显著抑制瘤生长和转移.
结论:
- 纳米颗粒显示出显著的潜力来增强当前的癌症化疗方案.
- 纳米技术的进步对于优化PtNP设计,交付和安全至关重要.
- 需要进一步的临床评估,以确定PtNP在瘤学中的全部治疗潜力.
更多相关视频
06:42Plasmonic Photothermal Cancer Therapy: Nanoparticle-embedded Tumor-tissue-mimicking Phantoms for Visualizing Photothermal Temperature Distribution
Published on: May 9, 2025
152
11:16Preparation of Silver-Palladium Alloyed Nanoparticles for Plasmonic Catalysis under Visible-Light Illumination
Published on: August 18, 2020
5.4K
相关概念视频
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Electron Transport Chain: Complex I and II
11.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
11.1K
